-
Zydus Cadila’s Covid vaccine to be launched in October: Report
This will be the first vaccine to be administered to the age group of 12 to 18 years in India.
-
PAN-Aadhaar linking deadline extended to September 30
The government also extended deadlines for various income tax compliances and said the amount paid by an employer to employees for Covid-19 treatment
-
Revised DGHS Covid guidelines drops these medicines for mild and asymptomatic patients
DGHS has prohibited the use of drugs such as hydroxychloroquine, ivermectin, doxycycline, zinc, multivitamins, etc. to asymptomatic and mildly symptom
-
DCGI approves anti-COVID drug developed by DRDO for emergency use
The approval to the drug has come at a time when India has been grappling with a record-breaking wave of coronavirus pandemic
-
Nirmala Sitharaman calls for sharing of technologies on COVID vaccines
Nirmala Sitharaman said there is a need to have a global multilateral approach to deal with the COVID pandemic.
-
Natco gets CDSCO nod for emergency use of Baricitinib tablets for Covid-19 treatment
Baricitinib in combination with Remdesivir is used for the treatment of COVID-19 positive patients
-
Zydus Cadila’s Virafin gets emergency authorisation for COVID-19 treatment
A single-dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients, Zydus Cadila said
-
Centre taking all steps to accelerate remdesivir production: Union minister
Chemicals and Fertilisers Minister D V Sadananda Gowda said that a total of 6.69 lakh vials of the drug have been made available to different states a
-
Ramping production of Remdesivir to meet demand: Pharma firms
In view of increased demand for the medicine due to a spike in COVID-19 cases, the Centre on Sunday prohibited the export of Remdesivir injection till
-
Policyholders prefer paying health insurance premium in EMIs amid Covid outbreak: Survey
Here is a primer on how health insurance premium is paid in instalments and how the claim settlement process works
